3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
11
Nasopharyngeal Carcinoma
6
Oropharyngeal Neoplasms
5
Prostatic Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma
4
Mouth Neoplasms
3
Hypopharyngeal Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mesothelioma
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Anus Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Mesothelioma, Malignant
1
Meningioma
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced Cervical Adenocarcinoma
1
HIV Infections
1
Glioma
1
Glioblastoma
1
Interventions
Specimen Handling
38
Biopsy
30
Magnetic Resonance Spectroscopy
24
pembrolizumab
14
trastuzumab deruxtecan
8
Radiosurgery
8
Nivolumab
8
Gemcitabine
8
Paclitaxel
7
Ipilimumab
6
Carboplatin
6
Capecitabine
6
palbociclib
5
X-Rays
5
Taxes
5
Radiation
5
Leucovorin
5
Fulvestrant
5
Fluorouracil
5
Pemetrexed
4
Oxaliplatin
4
Letrozole
4
Irinotecan
4
CTLA-4 Antigen
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
ribociclib
3
olaparib
3
ipatasertib
3
enzalutamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.